Palantir rose after earnings blew past Wall Street estimates, while shares of Vertex Pharmaceuticals and Hims & Hers ...

The latest meme stock mania may have faded, but retail investors are always looking out for the next short-squeeze. Data from ...

ASP Isotopes, a cutting edge player in nuclear and quantum materials, has surged an impressive 107% so far in 2025. The ...

Bottom line: Palantir continues to benefit from investor activity that is pricing the future, not the current P/E ratio into ...

U.S. stock indexes are slipping following the latest discouraging signal on the U.S. economy. The S&P 500 fell 0.4% Tuesday, ...

Clients of BofA Securities last week bought cyclical stocks at the fastest pace in years, according to a weekly report from a ...

Jay Hatfield, CEO and CIO at Infrastructure Capital Advisors, joins CNBC's 'Power Lunch' to discuss why he's neutral on the ...

Prudent pricing, exposure growth, solid retention, renewals, and improved digitalization are expected to help AIG, MFC, and ...

Global stocks rose for a second session on Tuesday and the U.S. dollar steadied as investors raised bets the Federal Reserve ...

FTSE 100 futures are up 0.4% as equity markets are set to extend a rebound into a second day. The pound is down a touch ...

Asian equities had a strong day, led by Australia, South Korea, Taiwan, Thailand, and Vietnam, while India underperformed, as ...

British equities closed modestly higher on Tuesday, led by a slew of upbeat corporate results, while investors assessed ...